From fluoroquinolones to 2-pyridones.
Hooper
D C
DC
Infectious Disease Unit, Massachusetts General Hospital, Boston, USA.
D042462:4-Quinolones; D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D004250:DNA Topoisomerases, Type II / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D011728:Pyridones / Q000494:pharmacology* / Q000627:therapeutic use; D012377:Rodentia
D042462:4-Quinolones; D000890:Anti-Infective Agents; D011728:Pyridones; C093440:ABT 719; D004250:DNA Topoisomerases, Type II